Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also weighed in on the company. HC Wainwright reissued a “neutral” rating and set a $6.60 price target on […]
More Stories
Private Advisor Group LLC Has $3.71 Million Position in Xcel Energy Inc. (NASDAQ:XEL)
Private Advisor Group LLC lessened its holdings in shares of Xcel Energy Inc. (NASDAQ:XEL – Free Report) by 2.7% in...
AMG National Trust Bank Increases Position in Meta Platforms, Inc. (NASDAQ:META)
AMG National Trust Bank grew its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 65.6% during the first...
JMG Financial Group Ltd. Acquires Shares of 493 Meta Platforms, Inc. (NASDAQ:META)
JMG Financial Group Ltd. purchased a new position in Meta Platforms, Inc. (NASDAQ:META – Free Report) during the 1st quarter,...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Parthenon LLC
Parthenon LLC decreased its holdings in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.8% in the 1st quarter, HoldingsChannel.com reports....
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Concord Asset Management LLC VA
Concord Asset Management LLC VA reduced its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 8.7% in the 1st...
Jackson Creek Investment Advisors LLC Sells 109 Shares of Meta Platforms, Inc. (NASDAQ:META)
Jackson Creek Investment Advisors LLC lowered its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 6.0% during the...